Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Antidiabetic agents reported by Boehringer Mannheim

June 14, 1996

rHb1.1 phase I trials begin in end-stage renal disease

June 14, 1996

SC-55494 effective in combination with rhG-CSF

June 14, 1996

CCK-A agonists revealed by Glaxo Wellcome

June 14, 1996

Warner-Lambert seeks approval for atorvastatin

June 14, 1996

Monsanto reveals benzothiazepines with novel activity

June 14, 1996

ACAT inhibitors from Sankyo

June 14, 1996

Hyperlipidemia treatment from Takeda

June 14, 1996

Ligand/Wyeth-Ayerst collaboration extended

June 14, 1996

Phase I trial to begin for aerosolized form of osteoporosis drug

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 25, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 25, 2025
Lost in trans-lation? Trump’s mouse charge doesn’t click
BioWorld
U.S. President Donald Trump touched off a not-uncommon flurry of puzzlement and outrage when, during his speech to Congress on March 4, he referred to an example...
Gene therapy efforts active, despite low Bluebird, 2seventy bids
BioWorld
Bristol Myers Squibb Co.’s decision this week to snag Bluebird Bio Inc. spinout 2seventy Bio Inc. for $102 million net – just weeks after investors bid $30...
CMV history cited in DMD liver death on Sarepta’s Elevidys
BioWorld
Wall Street was weighing the gravity of the death from acute liver failure of a patient who was treated for Duchenne muscular dystrophy (DMD) with Sarepta...